Researchers associate monoamine neurotransmitter abnormalities with depression, anxiety, and REM sleep behavior disorder, though not with cognition.

Step into the other side of translational medicine by working on a collaborative project.

A simple but powerful question: Can we reduce the chances that Parkinson’s disease develops in the first place?

FDA approval of bilateral pallidothalamic tractotomy using focused ultrasound creates an imperative to refine evidence-based patient selection criteria for two-sided brain ablation

Panel brings together epidemiologists, toxicologists, geneticists and neurologists to decipher the ways environmental factors and genetic predisposition contribute to PD risk and progression.

Movement Disorders Journal Symposium

The European Huntington’s Disease Network (EHDN) in collaboration with the International Parkinson and Movement Disorder Society- European Section (MDS-ES) is launching a joint Fellowship Exchange Programme in Huntington’s disease (HD-FEP)